News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
The provided content is a very short snippet related to Omnicom and its Q2 earnings, but it lacks any actual article text or financial information. It seems to be an incomplete or placeholder content.
Omnicom Group Inc. (NYSE:OMC) exceeded analyst expectations for its second-quarter results, with adjusted EPS of $2.65 and revenue of $6.6 billion. Despite this strong performance and a 4.7% gain during the regular session, the company's shares declined 2% in after-hours trading. The growth was …
Omnicom Group Inc. announced its Q2 revenue of $6.56 billion, surpassing the FactSet estimate of $6.44 billion. This financial update indicates a stronger-than-expected performance for the advertising and marketing giant in the second quarter. The company's results were published on July 28, 2026.
Omnicom (NYSE: OMC) reported a strong second quarter in 2026, with core operations revenue hitting $6.0 billion, driven by a 6.1% organic growth and a 1.1% foreign currency benefit. The company's Adjusted EBITA rose to $1.07 billion, pushing the margin to 17.8%, mainly due …
Omnicom (OMC) has announced strong second-quarter 2026 results, with revenue in its Core Operations growing 6.1% organically to $6.0 billion and a notable expansion in Non-GAAP Adjusted EBITA margin to 17.8%. The company reported diluted earnings per share of $2.08, or $2.65 non-GAAP adjusted, …
Sharemaestro market context Price above Trend Line 52 weeks +8.6% · Next-week setup negative 39.5%Omnicom Group (OMC) stock is up 4.7% today, likely due to investor anticipation ahead of its Q2 2026 earnings release. Optimism is also fueled by higher-than-expected cost synergies from its Interpublic combination and a significant share repurchase program. The article also provides details on …
Omnicom Group Inc. (OMC) reported its Q2 adjusted EPS at $2.65 per share, which fell slightly short of the FactSet estimate of $2.67. The company's Q2 revenue was $6.56 billion, surpassing FactSet's estimate of $6.44 billion. The earnings flash highlights the company's financial performance …
Omnicom Group Inc. is reporting second-quarter earnings, with investors keenly watching its execution of the Interpublic acquisition, particularly concerning integration progress, synergy targets, and client retention. Analysts anticipate significant year-over-year growth in EPS and revenue, largely driven by the acquisition. The focus will also …
Omnicom Group's stock reached a new 52-week high of $87.17, currently trading at $87.18 with a market capitalization of $24.79 billion. InvestingPro analysis suggests the stock is undervalued, offering a 3.88% dividend yield and having maintained dividend payments for 56 consecutive years. This milestone …
This article focuses on the enterprise value to EBIT forward for OmniAb, Inc. (NASDAQ:OABI). It indicates that financial data for this metric is provided by FactSet Research Systems Inc. and market data by ICE Data Services.
This article provides an in-depth analysis of Omnicom Group Inc. (NYSE: OMC) focusing on price-sensitive allocations, neutral sentiment, and potential trading strategies. It highlights an exceptional risk-reward short setup and offers AI-generated signals and institutional trading strategies for various risk profiles. The analysis suggests …
Omnicom Group Inc (NYSE: OMC) is preparing to announce its second-quarter earnings, with analysts forecasting significant increases in EPS and revenue. GuruFocus' GF Value™ suggests the stock is modestly undervalued by 12.9%, despite a high trailing P/E ratio, while its GF Score™ of 83 …
Somnigroup International Inc. announced the successful refinancing of its $2.9 billion senior secured credit facilities, including a $1.7 billion revolver and a $1.2 billion term loan A. This amendment lowers the company's cost of capital, extends debt maturities, and enhances financial flexibility. The transaction …
Veraxa Biotech has advanced its bispecific antibody-drug conjugate (ADC) program, VXA-222, into the next development phase after OmniAb completed its antibody discovery work. This collaboration utilizes OmniAb's transgenic antibody discovery platform and Veraxa’s proprietary ADC linker and conjugation technology to create a dual-antigen "AND-gate" …
VERAXA Biotech (NASDAQ: VRXA) has advanced its bispecific antibody-drug conjugate (bsADC) program, VXA-222, reaching a key technical milestone in its collaboration with OmniAb (NASDAQ: OABI). OmniAb completed its discovery work, moving the program to its next phase. VXA-222 is designed to target two tumor …
This article provides a detailed balance sheet for Omnicom Group Inc (OMC), outlining quarterly and annual financial data across various asset, liability, and equity categories. It includes historical data dating back several years, showing trends in cash, receivables, total assets, total liabilities, and shareholders' …
Marketers are facing a new creative paradigm called "connected content" due to media fragmentation, second screening, and AI. This model, proposed by Omnicom Media Intelligence, aims to integrate various channels like media, commerce, and creator marketing into content creation for more effective campaigns. It …
Omnicom Group, a Marketing and Advertising Services company, had approximately 121,985 total employees worldwide as of March 2026, representing a 3.7% growth since 2023. The company is actively hiring, though its active job postings declined by 24.3% in 2026 compared to 2025. Its workforce …
OmniAb Inc. (OABI) licenses discovery research technology to pharmaceutical and biotech companies, leveraging its OmniAb platform to identify optimal antibodies for drug development. The company utilizes engineered transgenic animals like OmniRat and OmniChicken to generate human sequence antibodies. OmniAb's top five shareholders include Mr. …
Veraxa Biotech AG announced that its bispecific antibody-drug conjugate program, VXA-222, advanced to the next development phase after completing discovery work with OmniAb, Inc. The program targets solid tumors using AND-gate logic, combining OmniAb's antibody discovery technologies with Veraxa's linker technology. Veraxa holds exclusive …
VERAXA Biotech announced the advancement of its bispecific ADC (bsADC) program VXA-222, developed in collaboration with OmniAb. This program, which uses an "AND-gate" logic to target solid tumors, has moved into its next phase following the successful completion of OmniAb's discovery work. VERAXA will …
Omnicom Group Inc. (MIL:1OMC) generated total revenue of €14.71 billion last year. Its top-performing segment, Media & Advertising, contributed €8.53 billion, an increase from €8.18 billion in the previous year. The United States was the largest geographical contributor, accounting for €7.75 billion, slightly down …
This article provides a detailed revenue breakdown for OmniAb Inc (OABI) across its business segments for various fiscal quarters and years. It highlights that the company's main revenue streams are service revenue, license and milestone revenue, royalty revenue, and xPloration revenue. The data is …
Omnicell Inc (OMCL) currently has an earnings forecast score of 8.00, placing it 68th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $47.00, with a majority recommending a "Buy" trend for the stock. The company's expected revenue …
Omnicom Group (OMC) Q2 Earnings: What To Expect Global advertising giant Omnicom Group (NYSE:OMC) will be announcing earnings results this Tuesday after market hours. Here's what investors should know. Omnicom Group beat analysts' revenue expectations last quarter, reporting revenues of $6.24 billion, up 69.2% …
Sharemaestro market context Price above Trend Line 52 weeks +8.6% · Next-week setup negative 39.5%This article provides the quarterly and annual balance sheets for OmniAb Inc (OABI), allowing users to assess the company's financial health, fundamentals, and key financial ratios. It details assets, liabilities, and shareholders' equity over recent fiscal quarters and years, along with frequently asked questions …
Omnicom Group stock demonstrates stable performance due to consistent revenue growth, strong margins, and shareholder-friendly capital allocation. The company, a major global advertising and marketing services provider, has shown year-over-year increases in revenue and net income, alongside solid EPS growth. This financial health supports …
This article provides a detailed quarterly and annual income statement analysis for OmniAb Inc (OABI). It outlines key financial metrics, including total revenue, operating expenses, net income, and earnings per share, along with year-over-year comparisons. The report also addresses frequently asked questions about interpreting …
This article provides a historical overview of dividend payouts and stock split information for Omnicom Group Inc (OMC). It details dividend dates, including record, payment, and ex-dividend dates, along with the gross cash dividend amounts. The data spans from late 2024 to late 2026, …
This article provides a valuation analysis of Omnicell Inc (OMCL), noting its current valuation score of 6.66, ranking 178 out of 200 in the Healthcare Equipment & Supplies industry. The company's P/E ratio stands at 91.94, which is significantly below its recent high but …
This article details the shareholder structure of Omnicom Group Inc (OMC), identifying its major institutional holders such as State Street Investment Management and Vanguard Capital Management. It provides a breakdown of shareholder types, institutional shareholding trends over recent quarters, and significant changes in individual …
Omnicom Group Inc. (OMC) stock gained 2.26% on Friday, closing at $79.66, despite the company's shares underperforming compared to key competitors. This occurred on a positive trading day where the S&P 500 Index rose 0.05% and the Dow Jones Industrial Average gained 0.46%. The …
This article provides an overview of Omnicell Inc (OMCL) stock, including its current trading price, market capitalization, and P/E ratio. It specifically addresses the company's dividend history, noting that no dividends have been distributed over the past five years. The page indicates there is …
This article provides an earnings forecast for Omnicom Group Inc. (OMC), detailing its current earnings forecast score, analyst ratings, and price targets. It also includes expected revenue and EPS for upcoming quarters and past performance.
Search by ticker symbol or company name and select a result to open its chart.